Search

Glaxosmithkline Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 1,220.00 -7.20  | -0.59% -14.22% 46.46 20,692.10
NSE Price: Jun 26, 15:59 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Jun 26, 15:59 1,220.00 -7.20 -0.59% 1,238.40 1,227.20 28,328 1,215.00 - 1,238.40
BSE Jun 26, 2019 1,221.45 -5.80 -0.47% 1,231.00 1,227.25 1,570 1,218.00 - 1,232.50
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 17,377 P/B: 9.67 NSE Code: GLAXO
52-Week Range: R 1,215.00 - 1,800.05 Dividend Yield: 1.64% BSE Code: 500660
TTM EPS: R 26.29 Book Value: R 126.31 Face Value: R 10
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Torrent Pharmaceuticals (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 38 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Glaxosmithkline Pharma -19.49 -4.66 -6.12 -14.22 -11.10 -0.19 7.04
S&P BSE Mid Cap* -4.95 -1.81 -1.62 -6.61 9.05 9.76 11.25
S&P BSE Healthcare* -8.54 -4.94 -9.78 -10.40 -5.15 3.06 13.17
Company's return has been calculated on basis of NSE's price.
As on Jun 26, 2019
*As on Jun 25, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 8.94 3.30 -
Net Profit 26.99 5.79 -
EPS 26.99 5.79 -
Book Value 4.01 -0.67 -
Average
Operating Margin 22.48 19.64 20.98
Net Margin 13.79 12.36 12.59
Return on Networth 21.22 18.19 19.65
Return on Investment 32.54 27.83 30.37
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -8.98 0.35 0.35
Operating Profit 40.56 24.90 24.90
Net Profit 8.91 16.56 16.56
EPS 8.90 16.55 16.55
TTM
Revenue 0.08 8.03 8.03
Operating Profit 6.48 25.98 25.98
Net Profit 4.29 20.85 20.85
EPS 4.28 20.85 20.85
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Glaxosmithkline Pharma 20,692.10 3,128.53 425.36 13.17 21.22 9.67 46.46
Cadila Healthcare 24,446.97 13,165.60 1,851.80 13.85 22.26 2.35 13.22
Torrent Pharmaceuticals 26,155.44 7,673.00 436.00 5.64 9.34 5.54 59.95
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Mar 31, 2017 GlaxoSmithKline Pte Ltd  Sell Off Market 3,192,238 2,744.55 87,612.57
Mar 30, 2017 GlaxoSmithK Line Pte Ltd  Buy Off Market 3,192,238 2,731.45 87,194.38
Mar 13, 2014 Glaxosmithkline Pte Ltd.  Buy Off Market 20,609,774 2,533.75 522,200.15
Fund Houses invested in the stock
Fund Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
Aditya Birla Sun Life Mutual Fund 2.574 2.427 2.340 2.300 2.301
L&T Mutual Fund 0.178 0.204 0.204 0.200 -
UTI Mutual Fund 0.128 0.128 0.128 0.138 0.139
Mahindra Mutual Fund 0.022 0.013 - - -
Reliance Mutual Fund 0.003 - 0.001 - -
Edelweiss Mutual Fund NA 0.024 0.024 - -
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Glaxosmithkline Pharmaceuticals Ltd.

Address: Dr Annie Besant Road, Worli, Mumbai, Maharashtra - 400030 | Phone: 022-24959595 | Fax: 022-24959494

Email: [email protected]

Website: www.gsk-india.com

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

comments powered by Disqus
Essential checks
Altman Z-Score
3.28
Piotroski F-Score
5
Modified C-Score
2
5-Years Price to Earnings
46.40
5-Years Price to Book
9.66
Earnings Yield
EBIT / Enterprise value
3.50%
PEG
Price / Earnings to growth ratio
63.25
Related Stocks
  Current Price   Chng %
Abbott India R8,775.80 +2.55%
Alkem Laboratories R1,696.90 -0.03%
Bayer CropScience R3,278.50 -2.72%
Cadila Healthcare R238.90 +3.69%
Glenmark Pharma. R453.35 -0.48%
Ipca Laboratories R927.85 -0.32%
Pfizer R3,254.45 +0.13%
Sanofi India R5,520.05 +0.36%
Syngene International R326.25 +0.22%
Torrent Pharmaceuticals R1,545.90 -0.03%
As on Jun 26, 15:59